SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-19-000040
Filing Date
2019-02-28
Accepted
2019-02-28 11:53:37
Documents
3
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER DATED FEBRUARY 2019 clementia6knomrd.htm 6-K 5558
2 OTICE OF ANNUAL GENERAL MEETING DATED FEBRUARY 28, 2019 exhibit99-1.htm EX-99.1 5227
3 clementia6knomrdx4x1.jpg GRAPHIC 5812
  Complete submission text file 0001176256-19-000040.txt   19994
Mailing Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5
Business Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 19641509
SIC: 2834 Pharmaceutical Preparations